Clinical trial
Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS)
NCT01276236 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS)
- Lead sponsor
- University of California, San Francisco
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 9, 2011
- Completion date
- April 30, 2015
- Enrollment
- 13 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
kaposi's sarcoma